phone icon  Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

Biomaterials (Bio Implants) Market

- Opportunities and Forecasts, 2014 -2020
 Report Code: LI 1589
 Pages: NA
 Format: PDF Exel CD_rom
pub_n Upcoming Date: Jun 2016
tab_nTables: NA
aut_nAuthor(s):

Biomaterials are artificially derived natural materials that are used in medical applications such as organ transplantation and replacement of tissues. The global market for medical devices was accounted to $240 billion in 2013. This shows the potential for growth of biomaterial market. Increase in aging population is the major driver for biomaterial market. Due to the increase in number of aging patients, the usage of biomaterial in wound healing, plastic surgery, neurology and tissue engineering is increasing. According to the Society for Biomaterials, there are more than 5000 novel research article published every year for improved wound care techniques and surgical devices. Biomaterials market growth is hindered by certain factors such as inflammatory responses and strict government regulations for commercialization. In 1999, Government of Norway conducted “Dental Biomaterial- Adverse Reaction Unit” activity to control and evaluate adverse implication in dental fields.

The global biomaterial market is challenged by above restraints; however, companies are developing novel techniques to overcome these challenges. Companies are collaborating to build extra competitive advantage in biomaterial market. For Example, Wright Medical Group recently acquired BioMimetic Therapeutics Inc. to explore opportunities for Wright’s Extermities business. This report provides key strategies adopted by top players engaged in this business. The report provides regulatory intelligence for biomaterial according to geographies.

Key companies included in the report are Morgan Tecxhnical Ceramics, BASF SE, Collagen Matrix Inc., Wright Medical Group Inc., Bayer AG, Kyocera Corporation, Cam Bioceramics BV, Ticona Gmbh, Noble Biomaterials Inc., and Biomet Inc

KEY BENEFITS

  • Key developmental strategies adopted by top market players engaged in this business to provide better understanding of potential opportunities and challenges in this market
  • Market estimation of applications, types of materials and geographic segment is derived from current market scenario and expected market trends
  • The report provides an in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to explore opportunities in specific regions
  • In depth analysis of key drivers, restraints and opportunities of biomaterials market with impact analysis
  • Value chain analysis, Porter’s five forces model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report

KEY MARKET SEGMENTSBY TYPE OF MATERIAL

  • Metals
  • Polymers
  • Ceramics
  • Natural Biomaterial

BY APPLICATION

  • Cardiovascular
  • Dental
  • Orthopedic
  • Wound Healing
  • Plastic Surgery
  • Ophthalmology
  • Tissue Engineering
  • Neurological Disorders
  • Others

BY GEOGRAPHY

  • North America
  • EMEA
  • Asia Pacific
  • ROW

KEY AUDIENCES

  • Medical device manufacturing companies
  • Pharmaceutical Companies
  • Research Institutes
  • Academic Institutes
Let us know more about your research need and we will customize an offer exclusively for you!
*
*
*
*
*
*
*
security
*

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$3951
$4660
$6432
$9345
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User $4515
$3951
Group User $5325
$4660
Site User $7350
$6432
Global User $10680
$9345
First time buyer ?
Check offers and discount
on this report
REQUEST QUOTE
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
    Jun 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Nonalcoholic Steatohepatitis (NASH) also known as silent disease is a type of fatty liver disease, which mainly affects people with diabetes and obesity. Symptoms of NASH are found among all demographics (from children to adults); however, they are more prevalent in younger people. Corner stage of cirrhosis is a form of NASH that can be reversed with proper medication.
    Aug 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.
    Jan 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Medical tourism can be broadly defined as travel across international borders with the purpose of availing medical treatment, which may or may not be available in one’s own country. This treatment may include a wide array of medical services; however, the most frequently availed services include, cancer treatment, orthopedic treatment, elective surgery, and fertility treatment.
    Apr 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Immunoprotein is a protein with immunological activity, which provides immunity against pathogenic organisms or substances. Immunoproteins form the integrated body system of tissues, organs, cells or cell products that neutralizes antigens. These proteins enable the diagnosis of various diseases as they display an abnormal increase in their blood concentration when in a diseased state. High prevalence of cancers, cardiovascular diseases, allergies, urological disorders and orthopaedic diseases are the major drivers of the global immunoprotein diagnostic testing market.
    Jun 2016 | View Details >>
  • ...
    Medical gases are meant to be administered to a patient for therapeutic, diagnostic or anesthetic purposes. These gases have wide application in healthcare. They are produced, distributed and facilitated through means of medical gas equipment. The main driver for this market is the U.S. Food and Drug Administration Safety and Innovation Act, implemented in July 2012,that enables manufacturers to control costs and to file for intellectual property rights for new medical gas and equipment products.
    Jun 2016 | View Details >>
  • ...
    Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patient’s oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.
    Jun 2016 | View Details >>